ARTICLE | Company News
Pharmstandard pharmaceuticals news
July 22, 2013 7:00 AM UTC
Pharmstandard said its board plans to spin off the company's branded OTC business. Pharmstandard reported 2012 net revenue of RUB12.7 billion ($416.6 million) from the OTC business, which represented 25% of Pharmstandard's 2012 net revenue of RUB51.4 billion ($1.7 billion). The spin-off is subject to shareholder approval at an extraordinary shareholder meeting on Sept. 27. The newco is slated to be operational in February or March 2014. ...